Medicine and Dentistry
Prostate Cancer
100%
Neoplasm
79%
Irritable Bowel Syndrome
46%
Diarrhea
41%
Prostate Biopsy
35%
Biopsy Technique
34%
Biological Marker
32%
Mast Cell
29%
Prostate Tumor
29%
Squamous Cell Carcinoma
26%
Cell Activation
25%
Prostate Specific Antigen
22%
High-Grade Prostatic Intraepithelial Neoplasia
22%
Malignant Neoplasm
22%
Jejunum
21%
Tumor Progression
20%
Rectum Cancer
19%
Diseases
15%
Clear Cell Renal Cell Carcinoma
15%
Signal Transduction
15%
Preoperative Radiotherapy
14%
Metastatic Carcinoma
13%
Protein P53
13%
Prostatectomy
13%
Clinical Significance
13%
Magnetic Resonance Imaging
13%
Immunoglobulin Producing Cell
13%
Cancer Diagnosis
12%
Jejunum Mucosa
11%
Gleason Score
11%
Jejunum Biopsy
10%
Transrectal Ultrasonography
10%
Gene Mutation
9%
Programmed Cell Death
9%
Immunohistochemistry
9%
Vasculotropin
9%
Prostate Hypertrophy
9%
Upregulation
9%
Epidermal Growth Factor Receptor
9%
Lymph Node
8%
Cancer Growth
8%
Cancer Cell
8%
down Regulation
8%
Receptor
7%
Melanoma
7%
Lymph Node Metastasis
7%
In Vitro
7%
Colon Carcinoma
7%
Bladder
7%
Messenger RNA
7%
Keyphrases
Prostate Cancer
86%
Irritable Bowel Syndrome
49%
Tumor
42%
Diarrhea-predominant Irritable Bowel Syndrome
39%
Prostate Cancer Screening
35%
Prostate Tumor
29%
Jejunum
27%
Prostate Biopsy
26%
Penile Squamous Cell Carcinoma
26%
Clinical Manifestations
21%
High Grade Prostatic Intraepithelial Neoplasia (HGPIN)
20%
Free PSA
19%
Prostate Volume
19%
Mast Cell Activation
18%
Prostatic Biopsy
18%
Aggressive Tumor
17%
Aggressive Prostate Cancer
15%
Total Prostate-specific Antigen
15%
Tumor Aggressiveness
14%
Postoperative Radiotherapy
14%
Clear Cell Renal Cell Carcinoma (ccRCC)
13%
High-grade Tumor
13%
Metabolic Syndrome
13%
Statins
13%
Colorectal Cancer
13%
Pathobiology
13%
Kidney Injury molecule-1 (KIM-1)
13%
Proliferative Inflammatory Atrophy
13%
Urinary Biomarkers
13%
Clinical Significance
13%
Tumor Progression
13%
Multiparametric MRI (mpMRI)
13%
Magnetic Resonance Imaging
13%
Mast Cells
12%
Gleason Score
12%
PSA Density
12%
Jejunal mucosa
12%
Radical Prostatectomy
11%
Patients with Prostate Cancer
10%
Digital Rectal Examination
10%
Penile Intraepithelial Neoplasia (PeIN)
10%
Prostate Cancer Progression
10%
Epithelial Barrier
10%
High-risk Human Papillomavirus (HR-HPV)
9%
Diarrhea
8%
Risk Factors
8%
MicroRNA
8%
Signaling Pathway
8%
Plasma Cells
8%
Patient Outcomes
8%
